NASDAQ$ALKS

Alkermes plc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Reported financial results for the second quarter of 2020 and provided updated financial expectations for full-year 2020.

Alkermes plc reported second quarter revenues of $247.5 million, GAAP net loss per share of $0.19 and diluted non-GAAP earnings per share of $0.06. The company is focused on commercial execution, aggressive development of pipeline programs, and efficient management of operating structure.

  • Total revenues for the quarter were $247.5 million.
  • GAAP net loss was $29.4 million for the quarter, or a GAAP net loss per share of $0.19.
  • Non-GAAP net income was $8.9 million for the quarter, or a non-GAAP basic and diluted earnings per share of $0.06.
  • At June 30, 2020, Alkermes recorded cash, cash equivalents and total investments of $539.6 million.

Headline financials

Total Revenue

$248M

Previous: $280M-11.6%
EPS (adj)

$0.06

Previous: $0.09-33.3%
Capital Expenditures

-$30.4M

Previous: -$39.5M+23.2%
Free Cash Flow

-$59.8M

Previous: -$81.5M+26.7%
Net Income

-$29.4M

Previous: -$42M+29.9%
Operating Income

-$33.7M

Previous: -$35.9M+6.3%
Gross Profit

$202M

Previous: $234M-13.3%
Cash & Equivalents

$189M

Previous: $196M-3.5%
Total Assets

$1.8B

Previous: $1.75B+2.9%

Revenue & EPS history

Alkermes · Revenue · Quarterly

$248M

Q2 2020-11.6%vs Q2 2019
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Alkermes · $130M total across 2 segments · Q2 2020

  • VIVITROL
    $71.6M-18.8%
  • ARISTADA
    $58.8M+21.5%

Forward guidance

The following financial expectations for 2020 reflect the anticipated net impacts of the COVID-19 pandemic on Alkermes’ operating and financial results. Alkermes anticipates that the negative impact of COVID-19 on VIVITROL net sales will be partially offset by a decrease in operating expenses, notably within R&D.

Tailwinds

  • Total Revenue $965 - $1,005 million
  • VIVITROL Net Sales $270 – $300 million
  • ARISTADA Net Sales $220 – $235 million
  • Non-GAAP Net Income $0 – $30 million
  • Non-GAAP Diluted EPS $0.00 – $0.19

Headwinds

  • Cost of Goods Sold $180 – $190 million
  • R&D Expenses $370 – $395 million
  • SG&A Expenses $525 – $550 million
  • GAAP Net Loss ($145) – ($175) million
  • GAAP Net Loss per Share ($0.91) – ($1.10)

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.6%

Avg return

Earnings day

-0.0%

Avg return

5 days after

-0.5%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+16.6%

Q4 2017

Best reaction

-14.8%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.2%+2.5%+27.0%
Q4 2025-6.6%-9.4%-12.0%
Q3 2025+3.9%+3.3%+0.0%
Q1 2025+6.3%+5.5%+6.4%
Q4 2024+4.8%+12.3%+6.5%
Q3 2024-6.3%-5.1%+3.3%
Q2 2024+12.2%+11.7%+11.8%
Q1 2024-2.8%-1.8%-4.6%
Q4 2023+15.0%+8.6%+2.7%
Q3 2023-2.4%-4.0%-3.7%
Q2 2023-1.8%-5.1%-11.9%
Q1 2023-7.1%-6.1%-3.9%
Q4 2022+4.0%+2.9%-3.6%
Q3 2022+3.8%+0.3%+12.2%
Q2 2022-9.7%-14.4%-16.5%
Q1 2022+9.8%+6.4%+12.5%
Q4 2021+8.8%+7.6%+12.1%
Q3 2021-8.2%-5.0%-28.7%
Q2 2021+5.9%+11.6%+28.9%
Q1 2021-3.2%-1.6%+0.8%
Q4 2020-11.8%-13.7%-15.3%
Q3 2020+5.6%+5.9%+20.2%
Q2 2020-8.8%-7.4%-19.0%
Q1 2020-14.8%-14.7%+1.6%
Q4 2019-7.0%-7.8%-15.5%
Q3 2019+5.7%+6.0%+13.9%
Q2 2019-10.2%+1.2%-12.3%
Q1 2019-12.2%-12.7%-31.1%
Q4 2018-1.2%+3.6%+3.3%
Q3 2018+3.0%+6.5%-11.6%
Q2 2018-0.1%-0.3%+2.0%
Q1 2018+1.5%+1.4%+3.9%
Q4 2017+16.6%+23.0%+12.0%
Q3 2017+0.7%-1.5%+3.2%
Q2 2017-4.1%-5.4%-12.4%
Q1 2017+2.0%+2.4%+1.0%
Q4 2016-2.9%-4.6%+3.7%
Q3 2016-1.4%+4.0%+8.4%
Q2 2016-3.6%-6.0%-14.1%
Q1 2016-2.0%
Q4 2015-1.4%
Q3 2015+7.6%
Q2 2015+2.4%
Q1 2015+3.1%
Q4 2014-3.4%
Q3 2014+7.7%
Q2 2014-7.2%
Q1 2014+3.2%
Q4 2013-7.7%
Q3 2013-3.7%
Q2 2013+3.5%
Q1 2013+3.9%
Q4 2010-1.0%
Q4 2012-9.9%
Q3 2012+2.2%
Q3 2011+2.2%
Q2 2011-7.7%
Q2 2012-7.7%
Q4 2011-7.7%
Q2 2010-3.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro